Remifentanil protects uterus against ischemia-reperfusion injury in rats

Autor: Sadik Sahin, Ozlem Bingol Ozakpinar, Serap Aktas, Yunus Oktay Atalay, Zafer Kucukodaci
Přispěvatelé: OMÜ
Rok vydání: 2015
Předmět:
Zdroj: Acta Cirurgica Brasileira, Volume: 30, Issue: 11, Pages: 756-761, Published: NOV 2015
Acta Cirúrgica Brasileira v.30 n.11 2015
Acta Cirúrgica Brasileira
Sociedade Brasileira para o Desenvolvimento da Pesquisa em Cirurgia (SBDPC)
instacron:SBDPC
Acta Cirurgica Brasileira, Vol 30, Iss 11, Pp 756-761 (2015)
ISSN: 0102-8650
Popis: Sahin, Sadik/0000-0002-7107-9719 WOS: 000367014300006 PubMed: 26647795 PURPOSE: To investigate the effects of remifentanil as an antioxidant and analyze the histopathologic, biochemical changes in experimental ischemia-reperfusion (I/R) exposed rat uteri. METHODS: Wistar albino rats were assigned to three groups (n = 7). 2h period of ischemia was followed by 1h of reperfusion in the I/R and the I/R-remifentanil groups. After ischemia, no drug was administered in the sham and I/R groups. In the I/R-remifentanil group, remifentanil infusion (2 mu g/kg/min) was started in the ischemia period, and continued until the end of reperfusion. After the ischemic and reperfusion period, the ischemic uterine horns were removed surgically for biochemical and histopathologic examination. Tissue damage scores (endometrial epithelial glandular leukocytosis, degeneration, and endometrial stromal changes) were examined. Malondialdehyde levels and catalase, superoxide dismutase enzyme activities in tissue were measured. RESULTS: We found significantly lower epithelial leukocytosis and cell degeneration in the I/R-remifentanil group (p
Databáze: OpenAIRE